The negotiated price for NHS use was not disclosed.

Pharm Exec details the career of Rajesh K. Rajpal, MD, the chief medical officer and global head of clinical and medical affairs at J&J Vision.

The FDA has pulled the Emergency Use Authorization (EUA) for AstraZeneca’s Evusheld (tixagevimab/cilgavimab) because, the agency says, more than 90 percent of the circulating SARS-CoV-2 variants in the U.S. are now resistant to it.

Denver, CO. – August 2, 2022 Today, Validcare announces the integration of Real-World Research (RWR) Ltd into the Validcare Digital 1st CRO platform.  RWR is a global leader in providing Real-World Evidence solutions to the pharmaceutical, biotech and medical device industries.  Dr. Stuart McCully, CEO of RWR said “Until now we’ve provided sponsors with the regulatory intelligence needed ...

The 2020s will transform how consumers and businesses interact with each other as vast amounts of personal and contextually relevant data will be generated. These changes will demand organizations implement a new framework for deploying and managing communications, for implementing innovative omnichannel marketing strategies and tools, and for acquiring and utilizing data. This whitepaper explains how to ...

As healthcare marketers strive to keep pace with data technologies for better targeting and conversion, budgeting for 2019 becomes a formidable challenge. Questions about competitive advantages and cost-effectiveness drive conversations. Yet, the focus of forward-thinkers is shifting to better data for targeting faster and sooner in the engagement lifecycle. “We are seeing a dramatic increase in ...